| Literature DB >> 27122724 |
Chia-Shan Hsieh1, Eric Y Chuang1, Jyh-Ming Jimmy Juang2, Juey-Jen Hwang2, Chuen-Den Tseng2, Fu-Tien Chiang2, Ling-Ping Lai2, Jiunn-Lee Lin2, Chia-Ti Tsai2.
Abstract
UNLABELLED: The International Human Genome Sequencing Consortium published the first draft of the human genome in the journal Nature in February 2001, providing the sequence of the entire genome's three billion base pairs. The Human Genome Project involves a concerted effort to better understand the human DNA sequence through identification of all the genes. The knowledge that can be derived from the genome could result in the development of novel diagnostic assays, targeted therapies and the improved ability to predict the onset, severity and progression of diseases. This has been made possible by many parallelized, high-throughput technologies such as next-generation sequencing. In this review, we discuss the possible application of next-generation sequencing in finding the susceptibility gene(s) or disease mechanism of an important human arrhythmia called atrial fibrillation. KEY WORDS: Arrhythmia; Atrial fibrillation; Genetics, Next-generation sequencing.Entities:
Year: 2013 PMID: 27122724 PMCID: PMC4804897
Source DB: PubMed Journal: Acta Cardiol Sin ISSN: 1011-6842 Impact factor: 2.672